A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. (Q52423311)
Jump to navigation
Jump to search
scientific article published in January 1991
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. |
scientific article published in January 1991 |
Statements
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. (English)
P Jakobsen
L Bastholt
M Dalmark
P Pfeiffer
D Petersen
S B Gjedde
E Sandberg
C Rose
O S Nielsen
H T Mouridsen
1 January 1991
28
6
465-469
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference